Sponsor or institution
Clinical trials and research at Barbara Ann Karmanos Cancer Institute
As of November 12, 2026, Find a Trial lists 17 clinical trials run by Barbara Ann Karmanos Cancer Institute that are recruiting, in United States. By phase: Phase 2 (5), Phase 1 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 17Clinical trials
- 1Country
Newest trials
All recruiting trials (17)
-
Culturally adapted online genetic counseling and testing education for African American cancer survivors
We will test a culturally adapted online genetic counseling program to see if it increases genetic counseling and genetic testing among African American breast, prostate, and colorectal cancer survivors.
-
Ask Questions About Clinical Trials: A Tool to Help Patients Discuss Trials
This study tests a patient-friendly brochure called the ASQ-CT to see if it helps adults with cancer, heart disease, or neurologic conditions talk with their providers about clinical trials.
-
TheraBionic P1 device in advanced HR-positive, HER2-negative breast cancer
This trial tests whether the TheraBionic P1 device can help women with advanced or metastatic HR-positive, HER2-negative breast cancer who have progressed on standard therapies, by looking at survival and disease control.
-
Adding TheraBionic P1 radiofrequency therapy to treatment for early-stage HR+ HER2- breast cancer
This study will try giving TheraBionic P1 amplitude-modulated radiofrequency therapy before surgery to see if it improves tumor response in women with early-stage, hormone receptor–positive, HER2-negative breast cancer.
-
Amplitude-modulated radiofrequency therapy plus fruquintinib for refractory metastatic colorectal cancer
This trial will test whether adding amplitude-modulated radiofrequency electromagnetic fields to the drug fruquintinib helps people with metastatic colorectal cancer that has not responded to standard treatments.
-
TheraBionic P1 device for advanced liver cancer
This will test whether the TheraBionic P1 device can help people with advanced hepatocellular carcinoma who have no standard treatment options live longer.
-
Metformin with chemotherapy and/or immunotherapy for advanced solid tumors
This trial tests whether taking metformin alone and then together with standard chemotherapy and/or immunotherapy is safe for adults with advanced solid tumors.
-
Disappearing markers for daily breast radiation delivery
This trial will test whether Magic Ink tattoos are as safe and remain visible as standard tattoo ink for women getting radiation after breast cancer surgery.
-
Social needs screening and connection program for Metro Detroit cancer survivors
This project will test whether cancer survivors in Metro Detroit can complete a social needs screening and be connected to community resources for food and digital access.
-
Combination treatment for metastatic pancreatic cancer using chemotherapy and a special device
This study is testing a new treatment for metastatic pancreatic cancer that combines chemotherapy with a special device to see if it helps patients better than current options.
-
Video education to boost knowledge and interest in cancer clinical trials
Adults in the Detroit area will watch a short educational video to see if it increases their knowledge about and interest in cancer clinical trials.
-
First-in-human Interferon-γ PET imaging to monitor immunotherapy response
This study will try a new PET imaging tracer ([89Zr]Zr-DFO-emapalumab) to detect tumors and early responses to immunotherapy in people with newly diagnosed non-small cell lung cancer.
-
Using dapagliflozin to treat renal AL amyloidosis
This study is testing if the medication dapagliflozin can help reduce protein levels in the urine of people with renal AL amyloidosis while allowing them to participate from home.
-
Using Iberdomide and Daratumumab for Maintenance After Stem Cell Transplant in Multiple Myeloma
This study is testing if a combination of Iberdomide and Daratumumab can help people with Multiple Myeloma who still have some disease after a stem cell transplant feel better and live longer.
-
Using a smartphone app to track diet in amyloidosis patients
This study is testing whether a smartphone app can help people with amyloidosis track their diet and weight changes over nine weeks.
-
Combining ONC201 with Paclitaxel for Ovarian Cancer Treatment
This study is testing if combining a new drug called ONC201 with paclitaxel can help people with hard-to-treat ovarian cancer feel better and live longer.
-
Cross-training program for cancer survivors
This study is testing a 12-week workout program for cancer survivors to see if it can improve their fitness, body shape, and overall quality of life compared to standard guidelines.
Quick answers
How many clinical trials run by Barbara Ann Karmanos Cancer Institute are recruiting right now?
17, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in United States. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 5, Phase 1: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.